Multi-state interventional psychiatry clinics offering TMS and ketamine therapy
Serenity Healthcare operates outpatient psychiatry clinics built around TMS, ketamine therapy and medication management, running clinical operations on eClinicalWorks with Waystar for revenue cycle. Hiring skews heavily toward clinical and front-desk support roles, and projects like clinic-launch playbooks and a multi-state marketing engine point to a footprint expansion, even as overall hiring velocity is slowing.
Notable leadership hires: Psychiatrist Medical Director, Regional Medical Director
Serenity Healthcare runs Serenity Mental Health Centers, an outpatient practice focused on interventional psychiatry. Its clinics treat conditions including depression, anxiety, PTSD, bipolar disorder, OCD and ADHD through TMS, ketamine therapy, ADHD testing and medication management. Founded in 2017 and headquartered in Lehi, Utah, the privately held company employs 51–200 people. It operates across multiple states with regional medical leadership and recruits in the United States and India.
Serenity Healthcare uses eClinicalWorks for clinical records and Waystar for revenue cycle, plus Azure, Intune, Purview, Dialpad, HubSpot, Marketo, Klaviyo, Monday.com and Power Automate.
Serenity Healthcare is headquartered in Lehi, Utah, and operates mental health clinics across multiple US states, with hiring in the United States and India.
The clinics offer Deep TMS, ketamine infusion therapy, ADHD testing and medication management for depression, anxiety, PTSD, bipolar disorder, OCD and ADHD.
Other companies in the same industry, closest in size
Serenity Healthcare's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →
This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.